Target intelligence / Profile preview

One-cut homeobox family messenger RNA 3' untranslated regions (ONECUT 3'UTRs)

Target
ONECUT 3'UTRs
Molecular classification
RNA, Untranslated region, Regulatory element
01

Overview

The ONECUT family mRNAs 3' untranslated regions (3'UTRs) serve as essential regulatory hubs for the post-transcriptional control of One-cut homeobox transcription factors, specifically ONECUT1 (HNF6), ONECUT2, and ONECUT3. These regions are characterized by conserved binding sites for microRNAs, such as miR-124, which modulate mRNA stability and translation to ensure proper tissue development and metabolic homeostasis (Lannoy et al., 2000, PubMed: 10806341). In the context of oncology, dysregulation of these 3'UTRs—often through microRNA depletion or alternative polyadenylation—results in the pathological overexpression of ONECUT proteins. For instance, ONECUT2 overexpression is a hallmark of neuroendocrine prostate cancer (NEPC) and is associated with increased metastatic potential and lineage plasticity (Guo et al., 2019, PubMed: 31142862). Therapeutic strategies targeting these 3'UTRs involve the use of microRNA mimics or antisense oligonucleotides (ASOs) to restore inhibitory control and suppress the oncogenic driver activity of the ONECUT family (Sun et al., 2018, PubMed: 29754081). While promising, challenges include achieving tissue-specific delivery and avoiding off-target effects inherent to modulating broad-acting transcription factor networks.

Other names
ONECUT1 3'UTRONECUT2 3'UTRONECUT3 3'UTRHNF6 3'UTRHNF-6 3'UTROC-1 3'UTROC-2 3'UTROC-3 3'UTR
02

Mechanism of action

Binding of microRNA mimics or antisense oligonucleotides to the 3'UTR sequence induces mRNA degradation or inhibits translation, thereby reducing the expression of ONECUT transcription factors.

03

Biological functions

Post-transcriptional regulationmRNA stabilityTranslation regulationCell differentiationDevelopmental signaling
04

Disease associations

CancerProstate cancerHepatocellular carcinomaPancreatic cancerNeurodevelopmental disorders
05

Safety considerations

Off-target effects of RNA-based therapiesSystemic toxicity of delivery vehiclesPotential disruption of normal developmental pathways regulated by ONECUT factors
06

Interacting drugs

MicroRNA-124 mimics

1 more in the full profile.

07

Biomarkers

ONECUT2 protein expressionmiR-124 expression levelsONECUT1 mRNA levels

Beyond the preview

Go deeper on One-cut homeobox family messenger RNA 3' untranslated regions (ONECUT 3'UTRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on One-cut homeobox family messenger RNA 3' untranslated regions (ONECUT 3'UTRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call